CTW NASDAQ Week ended 07 Aug 2026

Weekly Investor Report

CTW Cayman Class A Ordinary Shares · Communication Services · Electronic Gaming & Multimedia

Open interactive chart View report data
Latest close 2.48 USD
0.0% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 11.5% above the Trend Line and sits at 67.6% of its 52-week range. The latest completed week returned 0.0%, after a -4.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 57/100.

Setup score 42 out of 100
Latest Close 2.48 USD 7 Aug 2026
1W Return 0.0% latest completed week
4W Return -4.6% short-term follow-through
12W Return -15.1% quarterly tape
Trend Breadth 28.8% 15 of 52 weeks active
Volume Ratio 1.3x vs 13-week average
What is working
  • The trend backdrop is active with a 15-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 43.87% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.0% Latest completed week; four-week move -4.6%. Indicator stack 61/42 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.87% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 57/100 36 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.5% above the Trend Line and sits at 67.6% of its 52-week range. The latest completed week returned 0.0%, after a -4.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5312-week average 0.62

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership2/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.53Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.6% over four weeks, -15.1% over 12 weeks, and -8.8% over one year. The current trend has remained active for 15 consecutive weeks.

Performance by holding period

1W0.0%
4W-4.6%
12W-15.1%
26W90.0%
52W-8.8%
Active trend streak15 weeks
Active weeks in one year15
Trend breadth28.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.35Latest activity-pressure read.
Pressure change-18.9%Four-week change in activity pressure.
Leadership0.51Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 09 Aug 2026 Financial statements through 30 Apr 2026 Field coverage 94% Model confidence 92%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength9/100Blend of value, momentum, and quality. Underlying universe rank 92; rank 1 is best.
Value10/100Relative valuation strength. Underlying universe rank 91; rank 1 is best.
Quality66/100Profitability and accounting quality. Underlying universe rank 35; rank 1 is best.
Momentum14/100Medium-term price momentum. Underlying universe rank 87; rank 1 is best.
Growth30/100Revenue and earnings growth. Underlying universe rank 71; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
38.4x
Price divided by trailing earnings.
Price / sales
1.6x
Market value relative to trailing revenue.
EV / EBITDA
14.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
75.6%
Gross profit retained from each unit of revenue.
Operating margin
4.9%
Operating profit retained from revenue.
Free-cash-flow margin
0.8%
Free cash flow generated from revenue.
Return on invested capital
15.1%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
32.1%
Latest one-year revenue growth.
EPS growth
-87.2%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-69.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
4/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.3x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment57/100

Weighted news tone is neutral across 36 relevant articles.

10 positive · 25 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-21.0%Distance below the 52-week high.
13-week volatility8.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2611 weeks finished lower.
Best week+22.6%Week of 13 Feb.
Worst week-20.9%Week of 22 May.
Latest week+0.0%Week of 7 Aug.

Shape of recent returns

Strong gains12
Modest gains2
Flat weeks1
Modest losses4
Sharp losses7
Recent vol8.4%13-week weekly-return volatility.
Base vol10.3%52-week weekly-return volatility.
Up/down split24/26Count of positive and negative weeks in the 52-week window.
Average skew9.0% / -7.6%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape46/100

Trend, activity pressure, participation, and risk combine to a 46/100 tape read.

 Indicator analysis53/100

Latest 12-week confirmation: trend 12/12, activity pressure 4/12, relative leadership 2/12.

Activity pressure 0.53; No reversal markers Next-Week ExpectancyNegative 43.87%

Next-week expectancy is negative with a 43.87% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors24/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 69; Small Cap Core rank 90 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment57/100

Weighted news tone is neutral across 36 relevant articles.

CTW Revenue Breakdown – NASDAQ:CTW Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 20262.48 USD0.0%2.22 USD2.18 USD-0.350.51135.1KOn
31 Jul 20262.48 USD6.4%2.20 USD2.17 USD-0.374.85148.2KOn
24 Jul 20262.33 USD-4.9%2.18 USD2.17 USD-0.27-147.3KOn
17 Jul 20262.45 USD-5.8%2.16 USD2.16 USD-0.29-74.6KOn
10 Jul 20262.60 USD-2.1%2.14 USD2.16 USD-0.30-30.4KOn
3 Jul 20262.65 USD10.2%2.12 USD2.15 USD-0.22-174.0KOn
26 Jun 20262.41 USD3.9%2.11 USD2.14 USD-0.28-23.0KOn
19 Jun 20262.32 USD-4.5%2.10 USD2.13 USD-0.08-41.8KOn
12 Jun 20262.43 USD8.0%2.09 USD2.13 USD0.18-92.4KOn
5 Jun 20262.25 USD-10.0%2.09 USD2.12 USD0.51-59.6KOn
29 May 20262.50 USD8.2%2.09 USD2.12 USD0.84-38.7KOn
22 May 20262.31 USD-20.9%2.08 USD2.11 USD1.01-161.2KOn
15 May 20262.92 USD4.3%2.09 USD2.10 USD1.18-256.7KOn
8 May 20262.80 USD-2.4%2.07 USD2.08 USD1.13-168.8KOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context